- Aradigm Corporation ARDM shares dropped 57.1 percent to $2.25. Aradigm disclosed that it has met primary and secondary endpoint in ORBIT-4. However, it missed ORBIT-3 primary and secondary endpoint.
- Heat Biologics Inc HTBX shares tumbled 55.9 percent to $1.27 following a negative outcome of its bladder cancer study. Heat Biologics said its phase 2 trial of Vesigenurtacel-L (HS-410) in combination with BCG in patients with non-muscle invasive bladder cancer (NMIBC) failed to meet primary endpoint.
- Palatin Technologies, Inc. PTN declined 29.7 percent to $0.570. Palatin Technologies priced 25.38 million shares for $16.5 million in gross proceeds.
- Express, Inc. EXPR dropped 21.9 percent to $10.44 after the company issued a weak outlook for the fourth quarter.
- Bazaarvoice Inc BV shares declined 13.7 percent to $4.57. Bazaarvoice reported Q2 earnings of $0.02 per share on revenue of $50.4 million.
- FuelCell Energy Inc FCEL dropped 13.3 percent to $1.95 after the company announced plans to cut 17 percent of its workforce. The company also issued a weak sales forecast for the fourth quarter.
- Forward Pharma A/S FWP shares declined 11.6 percent to $19.56. Forward Pharma shares have increased 1.65 percent over the past 52 weeks, while the S&P 500 index has gained 4.57 percent in the same period.
- Guess?, Inc. GES shares fell 11.2 percent to $13.60 as the company reported weaker-than-expected earnings for its third quarter on Wednesday.
- Dollar General Corp. DG shares dropped 8 percent to $71.16 after the company posted downbeat Q3 earnings.
- Xencor Inc XNCR shares fell 4.3 percent to $24.45. Xencor priced its 4.585 million offering at $24 per share.
- Cerner Corporation CERN declined 3.7 percent to $47.92. Leerink Swann downgraded Cerner from Outperform to Market Perform.
- Quintiles IMS Holdings Inc Q shares dropped 3.3 percent to $74.33. Raymond James downgraded Quintiles IMS from Strong Buy to Market Perform.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
